Trials / Conditions / Atopic Keratoconjunctivitis
Atopic Keratoconjunctivitis
6 registered clinical trials studyying Atopic Keratoconjunctivitis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | An Efficacy and Safety Study of DFL24498 in the Treatment of AKC NCT07395232 | Dompé Farmaceutici S.p.A | Phase 3 |
| Active Not Recruiting | Ocular Comorbidity in Atopic Dermatitis NCT04973384 | Rigshospitalet, Denmark | — |
| Unknown | Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) NCT04296864 | Andover Eye Associates | Phase 2 |
| Unknown | Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Ato NCT03557203 | National Taiwan University Hospital | — |
| Completed | A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Alle NCT03379311 | Allakos Inc. | Phase 1 |
| Completed | Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis NCT00987467 | Johns Hopkins University | N/A |